Sciety had the opportunity to ask a few questions to Mats Nilsson, professor at SciLifeLab and co-founder of EMPE Diagnostics and several other biotechnology companies. In the interview he talks about EMPE Diagnostics’ planned establishment in India and and about the need for diagnostic tools in order to use the drugs that are available. He gives an insight into SciLifeLab as the platform for developing ideas and also his view on the role of research in society.

Read More

Hi Pavan! Tell us about the idea and vision of EMPE Diagnostics? “Our idea is to develop DNA-based diagnostics that are suitable for resource limited clinical laboratories in low- and middle-income countries. We have integrated proven technology for diagnosis of infectious diseases with technology that allows test results to be read quickly and easily without…

Read More

The Sciety investor syndicate recently made an investment of MSEK 9.1 in the company Cavis Technologies, which has developed Wirecath┬«, a patent-pending product for the diagnosis of coronary heart diseases. The new capital will be used to establish sales on the European market. “Only in Europe, over 1.5 million people die every year from coronary…

Read More